EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Da Cheng Qi Decoction attenuates LPS-induced intestinal injury in rats in association with modulation of CHI3L1-associated inflammatory signaling and metabolic alterations

daorong wu, tianfeng hua, qiuming song, tingyu wen, Min Yang

Digestion · 2026-11-05

DOI: 10.1159/dig/acmag036 ↗
AbstractBibliografische Angaben

Abstract

Abstract Introduction: Sepsis-induced intestinal injury (SII) is a life-threatening gastrointestinal complication characterized by intestinal barrier dysfunction, metabolic disturbance, and excessive inflammation, while effective targeted interventions remain limited. Da Cheng Qi Decoction (DCQD), a classical East Asian traditional medicine formula, has shown protective effects against sepsis-associated intestinal dysfunction; however, the molecular networks underlying its effects remain incompletely understood. Here, we integrated metabolomic and proteomic analyses with experimental validation to investigate the potential regulatory mechanisms associated with DCQD-mediated protection against SII. Methods: A rat SII model was established in male Sprague-Dawley rats by LPS induction, and an in vitro intestinal injury model was generated using LPS-stimulated human colonic epithelial cells (CCD841). Integrated metabolomic and proteomic profiling of ileal tissues, together with in vivo and in vitro validation experiments, was performed to characterize DCQD-associated metabolic and inflammatory alterations and identify potential molecular networks involved in its protective effects. Results: Multi-omics identified 11 altered metabolites and 22 differentially expressed proteins after DCQD treatment, with CHI3L1 prioritized as a candidate molecule through exploratory multi-omics analysis and associated with bile acid and glucose metabolism (P < 0.05). In vitro, CHI3L1 silencing or DCQD-containing serum alleviated LPS-induced cellular injury (P < 0.01), and combined intervention showed enhanced protective effects on CCD841 cells, including improved cell viability, reduced apoptosis, and decreased secretion of IL-6, IL-1β, and TNF-α (all P < 0.05). In vivo, DCQD administration or CHI3L1 silencing ameliorated ileal histopathological injury, reduced inflammatory cytokine levels, improved intestinal barrier-related dysfunction reflected by citrulline and D-lactate levels, and decreased JAK2/STAT3 phosphorylation. These findings suggest that modulation of CHI3L1-associated inflammatory signaling may contribute to the protective effects of DCQD against SII. Conclusions: The present findings suggest that DCQD attenuates SII and is associated with modulation of metabolic alterations and CHI3L1-associated inflammatory signaling responses. CHI3L1 may represent a potential molecular mediator involved in SII progression and DCQD-mediated protection. These exploratory findings provide preliminary insights into the molecular networks associated with the protective effects of DCQD against septic intestinal injury.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →